March 26, 2026
Last week, the Minnesota Department of Health (MDH) issued a health advisory that extends the use of RSV Monoclonal Antibodies through April 30.
Physicians are advised to:
Continue administering RSV monoclonal antibody products (RSV-mAbs) to eligible infants and young children through April 30, 2026.
Use your electronic health record (EHR) or other system to pull lists of clients due for RSV-mAbs, and conduct outreach to those clients to encourage them to receive a dose before the end of the extended respiratory season.
Continue to advise patients and caregivers to take measures to prevent the spread of respiratory illnesses, including staying home when sick, practicing good hand hygiene, covering coughs and sneezes, and keeping infants away from individuals who are ill.
Report RSV-associated hospitalizations according to Minnesota Department of Health (MDH) reporting guidance.
See the full advisory here.
August 6, 2026
This year's Empowering Physicians event will feature an insightful panel discussion covering the emerging trends, risks and reforms of medical liability in Minnesota.
August 6, 2026
Looking to grow your leadership skills? Register today for the 2026-2027 cohort of the MMA’s Minnesota Physician Leadership Institute (MNPLI), which begins September 10.
August 6, 2026
The Minnesota Board of Medical Practice (BMP) is seeking a physician to fill an at-large vacancy. Interested physicians should apply on the Minnesota Secretary of State website.